论文部分内容阅读
阿司匹林是缺血性脑卒中患者急性期治疗药物及卒中再发的二级预防常用药物,骨髓间充质干细胞(BMSCs)移植是治疗缺血性脑血管疾病的新的新兴技术。已证实阿司匹林可抑制骨髓间充质干细胞的增殖及影响骨髓间充质干细胞的分化。本文就阿司匹林对骨髓间充质干细胞移植治疗缺血性脑卒中的影响等进行综述。
Aspirin is a commonly used secondary prevention drug for patients with acute ischemic stroke and recurrent stroke. Bone marrow mesenchymal stem cells (BMSCs) transplantation is a new and emerging technology in the treatment of ischemic cerebrovascular diseases. Aspirin has been proved to inhibit bone marrow mesenchymal stem cell proliferation and affect bone marrow mesenchymal stem cell differentiation. This article reviews the impact of aspirin on bone marrow mesenchymal stem cell transplantation in the treatment of ischemic stroke.